NCT01808157View on ClinicalTrials.gov

A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL

Enrollment

188

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Atopic Dermatitis

Interventions

DRUG

CT327 ointment

DRUG

placebo

Trial Locations (1)

Unknown

Synexus, Manchester, Lancashire, Midlands, Wales, Scotland

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Creabilis SA

INDUSTRY